Healthcare Solutions Management Group, Inc.
HSMD · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 72,339.77 | 1,723.57 |
| FCF Yield | 0.00% | 0.00% | 0.00% | -0.00% |
| EV / EBITDA | -17.82 | -21,530,693.95 | 0.00 | 2,541.13 |
| Quality | ||||
| ROIC | -1.02% | -0.84% | 0.00% | -0.00% |
| Gross Margin | 24.58% | 100.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 5.80 | 0.05 | 1.65 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | 33.30% | 21.69% | 32.11% | 80.39% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | -100.02% |
| Safety | ||||
| Net Debt / EBITDA | -17.82 | -572,821.68 | 0.00 | 52.18 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 12.76 | 27.47 | 0.00 | 0.00 |